The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells.
| Autor: | Thijssen R, Ter Burg J, van Bochove GG, de Rooij MF, Kuil A, Jansen MH, Kuijpers TW, Baars JW, Virone-Oddos A, Spaargaren M, Egile C, van Oers MH, Eldering E, Kersten MJ, Kater AP |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Leukemia [Leukemia] 2016 Sep; Vol. 30 (9), pp. 1963. |
| DOI: | 10.1038/leu.2016.184 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink